Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
33.02B | 30.80B | 29.46B | 28.12B | 22.05B | 27.49B | Gross Profit |
9.18B | 9.93B | 7.96B | 7.09B | 5.30B | 6.99B | EBIT |
2.68B | 4.16B | 3.10B | 2.88B | 1.36B | 2.48B | EBITDA |
3.46B | 5.25B | 3.96B | 3.90B | 2.40B | 3.03B | Net Income Common Stockholders |
2.22B | 2.74B | 2.22B | 2.31B | 1.25B | 2.12B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
12.38B | 15.33B | 13.84B | 13.73B | 11.90B | 10.46B | Total Assets |
59.05B | 56.78B | 47.67B | 47.34B | 42.26B | 37.59B | Total Debt |
4.32B | 1.98B | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-7.83B | -12.52B | -13.84B | -13.73B | -11.90B | -10.26B | Total Liabilities |
21.29B | 17.02B | 11.65B | 13.42B | 10.53B | 8.24B | Stockholders Equity |
37.51B | 39.42B | 35.71B | 33.65B | 31.49B | 29.19B |
Cash Flow | Free Cash Flow | ||||
0.00 | -236.00M | 996.00M | 2.31B | 1.94B | 653.44M | Operating Cash Flow |
0.00 | 525.00M | 1.25B | 2.69B | 2.69B | 3.25B | Investing Cash Flow |
0.00 | 116.00M | -392.00M | -714.00M | -688.74M | -1.80B | Financing Cash Flow |
0.00 | 1.20B | -848.00M | -848.00M | -681.56M | -543.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $829.09B | 13.87 | 8.10% | 2.10% | 7.44% | -5.08% | |
69 Neutral | $1.50T | 17.00 | 12.94% | 1.61% | 15.31% | ― | |
68 Neutral | $364.12B | 28.34 | 1.72% | 4.19% | -0.38% | -65.61% | |
67 Neutral | ¥31.94B | 23.92 | 2.38% | 20.66% | 4.26% | ||
64 Neutral | $4.44B | 11.99 | 5.16% | 249.23% | 4.01% | -11.87% | |
63 Neutral | $444.30B | 50.40 | 2.48% | 3.87% | 2.63% | -34.53% | |
52 Neutral | ¥299.06B | 29.74 | 5.25% | -3.42% | -35.09% |